5522 results for "*oma"

in 9.68 milliseconds.

• Melanoma Study Commitee

  Dac EGAC00001002788

• DAC Sysbio Melanoma

  Dac EGAC00001002793

• Lymphoma Biology and Survival / Applied Tumor Genomics / University of Helsinki

  Dac EGAC00001002849

• Somatic mutations predict an aggressive phenotype in meningioma but do not drive grade progression

  Dac EGAC00001002858

• Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing

  Dac EGAC00001002881

• Data Access Committee for Pediatric Medulloblastoma

  Dac EGAC00001002896

• Follicular lymphoma at diagnosis, treated in first line with immunochemotherapy Data Acces Comitee

  Dac EGAC00001002912

• HCV lymphoma exome sequencing Data Access Commitee

  Dac EGAC00001002999

• Multiple myeloma long-term survivor data access commitee

  Dac EGAC00001003078

• DAC Myeloma Genomic Lab

  Dac EGAC00001003079

• Melanoma Institute Australia Data Access Committee

  Dac EGAC00001003081

• LOGGIC-OE0497_ped_glioma-DAC

  Dac EGAC00001003147

• Multiple myeloma follow-up Data Access Commitee

  Dac EGAC00001003155

• Study of the microenvironment of angioimmunoblastic T-cell lymphoma

  Dac EGAC00001002756

• Linked-Read Medulloblastoma DAC

  Dac EGAC00001003236

• The Leeds Melanoma Cohort gene expression data access committee

  Dac EGAC00001000893

• Pediatric Sarcoma PDX whole exome sequencing dataset

  Data access policy to access Pediatric Sarcoma PDX whole exome sequencing dataset

  Dac EGAC50000000051

• HGSC lines: ATACseq and RNAseq, pre- vs post-treatment with HKMTi-1-005

  Formation of a DAC to support the deposition of RNAseq and ATACseq data, from pre- vs post-treatment high-grade serous ovarian carcinoma cell lines. The lines include PEO1, PEO4, PEA2, OVCAR5, OVCAR8, and the treatment includes use of a novel epigenetic drug called HKMTi-1-005.

  Dac EGAC50000000034

• DAC for "Integrated genetic analysis of primary CNS lymphoma"

  Dac EGAC00001003233

• DAC for glioblastoma studies

  Dac EGAC00001003461

• DAC for YCC Sarcoma

  Access can be granted by contacting Hyo Song Kim (hyosong77@yuhs.ac).

  Dac EGAC50000000046

• tRCC UTSW 2024 Cohort

  This submission contains the WES and RNA-Seq raw data for the study titled 'Comparative Genomics of a Translocation Renal Cell Carcinoma Mouse Model Reveals Molecular Mechanisms of Tumorigenesis.

  Dac EGAC50000000105

• Longitudinal dynamics in relapsed and refractory Hodgkin lymphoma Data Commitee

  Dac EGAC50000000108

• CRUK Oesophageal Adenocarcinoma Neoantigen Data Access Commitee

  Dac EGAC00001002496

• Servicio Hematología_Hospital Universitario de Salamanca_Spain

  Data obtained from Diffuse large B-cell Lymphoma cases from the Haematology Service at the University Hospital of Salamanca. The study was approved by the local Institutional Review Board, and written informed consent, following the Declaration of Helsinki, was obtained from all patients before sample collection.

  Dac EGAC50000000155